RS2414577 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (18)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| 1-stearoyl-2-oleoyl-GPE (18:0/18:1) levels | C | OR: 0.23 | 7E-47 | PubMed |
| Postprandial mean diameter of LDL particles | C | OR: 0.26 | 1E-31 | PubMed |
| Fasting mean diameter of LDL particles | C | OR: 0.22 | 1E-26 | PubMed |
| Postprandial triglycerides levels in very large HDL | C | OR: 0.23 | 3E-24 | PubMed |
| Phosphatidylethanolamine (38:4) levels | C | OR: 0.42 | 8E-21 | PubMed |
| Cholesteryl esters to total lipids ratio in large HDL | T | β: 0.038 | 9E-21 | PubMed |
| Age-related macular degeneration or COVID-19 critical illness (MTAG) | — | β: 0.06 | 3E-16 | PubMed |
| Age-related macular degeneration or COVID-19 infection (MTAG) | — | β: 0.06 | 3E-16 | PubMed |
| Age-related macular degeneration or COVID-19 hospitalization (MTAG) | — | β: 0.06 | 4E-16 | PubMed |
| Postprandial triglycerides in HDL | C | OR: 0.18 | 1E-15 | PubMed |
| Polyunsaturated fatty acids to total fatty acids percentage | C | — | 3E-15 | PubMed |
| red blood cell count (RBC, maximum, inv-norm transformed) | T | β: 0.02 | 4E-12 | PubMed |
| 1,2-dilinoleoyl-GPE (18:2/18:2) levels | C | OR: 0.12 | 4E-11 | PubMed |
| Phosphatidylcholine acyl-alkyl C38:2 levels | C | OR: 6.29 | 3E-10 | PubMed |
| Phospholipids to total lipids ratio in small LDL | T | β: 0.026 | 1E-9 | PubMed |
| Phosphatidylethanolamine (36:2) levels | C | OR: 0.28 | 1E-9 | PubMed |
| Lysophosphatidylethanolamine levels | C | OR: 0.19 | 7E-9 | PubMed |
| Phosphatidylethanolamine (36:4) levels | C | OR: 0.26 | 9E-9 | PubMed |